Evidence map›Paper›PMID 39445807›Full record

ArticlemBio2024

Mechanisms of

Lauren J Gonsalves, Allyson Tran, Tessa Gardiner, Tiia Freeman, Angshita Dutta, Carson J Miller, Sharon McNamara, Adam Waalkes, Dustin R Long, Stephen J Salipante and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lauren J GonsalvesDepartment of Microbiology, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-1718-2309
Allyson TranDivision of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, USA.
Tessa GardinerDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Tiia FreemanDivision of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, USA.
Angshita DuttaDivision of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, USA.
Carson J MillerDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Sharon McNamaraPulmonary Division, Seattle Children's Hospital, Seattle, Washington, USA.
Adam WaalkesDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-5202-1108
Dustin R LongDivision of Critical Care Medicine, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington, USA.
Stephen J SalipanteDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-8355-6992
Lucas R HoffmanDepartment of Microbiology, University of Washington, Seattle, Washington, USA.
Daniel J WolterDivision of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-4321-8520

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI PRADEEP k SINGH · 2010 to 2026
$21.4M
NRSA Training CoreTL1TR002318 · NCATS · UNIVERSITY OF WASHINGTON · PI Megan Moore · 2017 to 2026
$8.4M
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric diseaseK24HL141669 · NHLBI · UNIVERSITY OF WASHINGTON · PI Lucas R Hoffman · 2018 to 2026
$929k
Cystic Fibrosis Foundation (CFF) HOFFMA16G0Cystic Fibrosis Foundation (CFF) SINGH19R0Cystic Fibrosis Foundation (CFF) WOLTER20GOHHS | National Institutes of Health (NIH) K24HL141669NCATS NIH HHS TL1 TR002318NHLBI NIH HHS K24 HL141669NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

Trimethoprim-sulfamethoxazole (SXT) is commonly used to treat diverse

Indexed as

Anti-Bacterial AgentsReactive Oxygen SpeciesStaphylococcal InfectionsStaphylococcus aureusTrimethoprim, Sulfamethoxazole Drug CombinationCystic FibrosisHumansMicrobial ViabilityMutationThymidineAnti-Bacterial AgentsReactive Oxygen SpeciesThymidineTrimethoprim, Sulfamethoxazole Drug Combinationantibiotic resistanceantifolate drugspersistenceStaphylococcus aureusthymineless death

Identifiers

PMID39445807
PMCPMC11559000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.